Has anyone heard of or practices using a method of administering P2Y receptor agonists such as certain dinucleotides to a subject to remove pathological fluid accumulation in subretinal and intra-retinal spaces.
Has anyone heard of or practices using a method of administering P2Y receptor agonists such as certain dinucleotides to a subject to remove pathological fluid accumulation in subretinal and intra-retinal spaces.
If any of us opticians and O.D.'s has we practicing way beyond the scope of opticianry. You might try the CLAO or Other OMD sites.
uummmm what ?
There are currently 1 users browsing this thread. (0 members and 1 guests)
Bookmarks